Literature DB >> 1358797

Evolution of a highly polymorphic human cytochrome P450 gene cluster: CYP2D6.

M H Heim1, U A Meyer.   

Abstract

The CYP2D gene cluster on human chromosome 22 containing the functional cytochrome P450 gene CYP2D6 and two or three highly homologous pseudogenes is involved in a clinically important variation in the inactivation of drugs and environmental chemicals. Several mutant haplotypes of CYP2D6 have been identified by restriction analysis and by PCR-based allele-specific amplification. To understand the evolutionary sequence of mutational events as well as recently discovered interracial differences, we analyzed the arrangement of the CYP2D haplotype containing a common mutant allele of CYP2D6 associated with a XbaI 44-kb fragment. This haplotype contains four CYP2D genes instead of three. Comparison of the sequences of these genes with those of previously characterized haplotypes suggests that an early point mutation was followed by a crossover and a gene conversion event, the latter found preferentially in Caucasians. These data are consistent with the rapid evolution of this locus during "plant-animal warfare" with practical consequences for present-day defense of the organism against environmental adversity.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1358797     DOI: 10.1016/s0888-7543(05)80282-4

Source DB:  PubMed          Journal:  Genomics        ISSN: 0888-7543            Impact factor:   5.736


  30 in total

Review 1.  Molecular genetics of CYP2D6: clinical relevance with focus on psychotropic drugs.

Authors:  Leif Bertilsson; Marja-Liisa Dahl; Per Dalén; Ayman Al-Shurbaji
Journal:  Br J Clin Pharmacol       Date:  2002-02       Impact factor: 4.335

Review 2.  Polymorphic cytochromes P450 and drugs used in psychiatry.

Authors:  R T Coutts; L J Urichuk
Journal:  Cell Mol Neurobiol       Date:  1999-06       Impact factor: 5.046

3.  CYP2D6 genotype and phenotype determination in a Mexican Mestizo population.

Authors:  Marisol López; Jorge Guerrero; Helgi Jung-Cook; María Elisa Alonso
Journal:  Eur J Clin Pharmacol       Date:  2005-10-26       Impact factor: 2.953

4.  Conserved promoter elements in the CYP6B gene family suggest common ancestry for cytochrome P450 monooxygenases mediating furanocoumarin detoxification.

Authors:  C F Hung; R Holzmacher; E Connolly; M R Berenbaum; M A Schuler
Journal:  Proc Natl Acad Sci U S A       Date:  1996-10-29       Impact factor: 11.205

5.  The cytochrome P450 genesis locus: the origin and evolution of animal cytochrome P450s.

Authors:  David R Nelson; Jared V Goldstone; John J Stegeman
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2013-01-06       Impact factor: 6.237

Review 6.  Molecular genetics of cytochrome P450 IID. Anomalies of drug metabolism.

Authors:  E Jacqz-Aigrain; S Panserat; L Sica; R Krishnamoorthy
Journal:  Clin Rev Allergy Immunol       Date:  1995       Impact factor: 8.667

7.  CYP2D6 genotype determination in the Danish population.

Authors:  K Brøsen; P N Nielsen; K Brusgaard; L F Gram; K Skjødt
Journal:  Eur J Clin Pharmacol       Date:  1994       Impact factor: 2.953

8.  Three new alternative splicing variants of human cytochrome P450 2D6 mRNA in human extratumoral liver tissue.

Authors:  Jian Zhuge; Ying-Nian Yu
Journal:  World J Gastroenterol       Date:  2004-11-15       Impact factor: 5.742

9.  Human copy number polymorphic genes.

Authors:  J A Bailey; J M Kidd; E E Eichler
Journal:  Cytogenet Genome Res       Date:  2009-03-11       Impact factor: 1.636

Review 10.  Geographical/interracial differences in polymorphic drug oxidation. Current state of knowledge of cytochromes P450 (CYP) 2D6 and 2C19.

Authors:  L Bertilsson
Journal:  Clin Pharmacokinet       Date:  1995-09       Impact factor: 6.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.